Thermal denervation devices

Information

  • Patent Grant
  • 8882764
  • Patent Number
    8,882,764
  • Date Filed
    Friday, October 19, 2012
    12 years ago
  • Date Issued
    Tuesday, November 11, 2014
    10 years ago
Abstract
A method and apparatus for treating an intraosseous nerve. The method includes positioning a hollow shaft through the cortical shell of a vertebral body and into a cancellous bone region of the vertebral body. The hollow shaft includes an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and a first window extending transversely through the annular wall. An electrosurgical probe is advanced within the longitudinal bore from the proximal portion toward the distal portion. The electrosurgical probe includes a first treatment element at a distal end of the probe, wherein the first treatment element being in electrical connection with a power supply. The first treatment element is slidably disposed within the longitudinal bore so that the first treatment element is advanced radially outward from the window and shaft to affect treatment of the intraosseous nerve within the cancellous bone region.
Description
BACKGROUND OF THE INVENTION

In an effort to reduce back pain through early intervention techniques, some investigators have focused upon nerves contained within the vertebral bodies.


For example, PCT Patent Publication No. WO 01/0157655 (“Heggeness”) discloses ablating nerves contained within the vertebral body by first boring into the vertebral body with a nerve ablation device, placing the tip of the device in close proximity to the nerve, and then ablating the nerves with the tip. Heggeness discloses numerous devices, such as electricity transmitting probes, as candidate nerve ablation devices. In describing how to use such a probe, Heggeness discloses “raising the temperature of tip 24 such that the intraosseous nerve is ablated by the heat generated by electrical current passing through tip.” See Heggeness at page 8, line 28. The probe disclosed by Heggeness appears to be a solid metal rod functioning as the active electrode of a monopolar RF device.


U.S. Pat. No. 6,478,793 (“Cosman”) discloses ablative treatment of metastatic bone tumors, including those within the spine. Pain relief is reportedly achieved by penetrating the bone wall with a suitable probe, and applying heat through the probe to ablate either the bone tumor or the tissue near the bone tumor. Cosman teaches the use of both monopolar and bipolar probes in this application. See Cosman at col. 5, line 44. Cosman also teaches that the treatment may also be used to ablate the nerves and nerve ramifications in and/or around the bone to desensitize them against further tumor encroachment. See Cosman at col. 8, lines 50-65, and col. 9, lines 9-17.


The only probes specifically disclosed by Cosman appear to be monopolar. However, monopolar approaches require the use of a grounding pad beneath the patient and allows energy to flow from the probe and to dissipate in the surrounding tissue. Because the path by which the energy flows from a monopolar probe to its corresponding pad is uncontrolled, the energy may undesirably flow through sensitive tissue, such as the spinal cord. Since this method may cause undesired local muscle or nerve stimulation, it may be difficult or dangerous to operate in sensitive areas of the human body.


Cosman teaches that the electrode may be rigid and robust and capable of piercing bone. Cosman teaches that the electrode may comprise a metal tubular shaft (with appropriate wall thickness to prevent buckling or bending during penetration of hard bone) with a rugged pointed tip. See Cosman at col. 6, lines 34-46. Beyond teaching the use of a generic bipolar probe, Cosman does not disclose any particular bipolar electrode configuration.


U.S. Pat. No. 6,168,593 (“Sharkey”) discloses thermal probes in which the electrodes are disposed at an angle to the longitudinal axis of the probe. In one embodiment, an electrode is located in a laterally-disposed window of a tubular, electrically insulating shaft. See FIG. 1A. According to Sharkey, this electrode can ablate tissue at an angle to the principal axis of the probe.


Although the probe disclosed in FIG. 1A of Sharkey appears to be monopolar, Sharkey also teaches that “bipolar delivery can be implemented using the techniques of the current invention by providing at least two distinct elements on the tip, each connected to outgoing and return electrical paths from the RF power supply.”


Sharkey does not disclose a return and an active electrode located within the same window. Sharkey does not disclose a window in a conductive shaft. Sharkey does not disclose a probe having a tip adapted to penetrate bone.


U.S. Pat. No. 5,944,715 (“Goble”) discloses electrosurgical instruments wherein active electrodes 14 are housed within a window of an insulator. See FIGS. 1 and 4.


Like Sharkey, Goble does not disclose a return and an active electrode located within the same window, nor a window in a conductive shaft, nor a probe having a tip adapted to penetrate bone.


SUMMARY OF THE INVENTION

The present inventors have found that the shaft of a bipolar probe adapted to penetrate bone can be made by simply joining a solid, sharp tip onto a hollow tube. The resulting shaft is of sufficient strength to penetrate the cortical shell of a vertebral body. Furthermore, since the shaft comprises a hollow tube, wires for an electrode can be housed within the tube, thereby allowing a bipolar or sesquipolar configuration. The combination of the ability to penetrate a cortical shell and the ability to provide bipolar or sesquipolar function represents an advance over the conventional technology.


Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:

    • a) a hollow shaft having an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and a first window extending transversely through the annular wall, and
    • b) a first electrode disposed within the window and being in electrical connection with a power supply, and
    • c) a tip having a proximal end portion, a sharp tipped distal end adapted to penetrate cortical bone, the proximal end portion of the tip mechanically connected to the distal portion of the bore of the hollow shaft.


In some embodiments, a space is provided between the tip and tube for ease of manufacturing.


Also in accordance with the present invention, there is provided an electrosurgical device, comprising:

    • a) a hollow shaft having an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and
    • b) an electrically insulating spacer having a proximal end and a distal end portion, the proximal end being mechanically connected to the distal portion of the bore of the hollow shaft.


In another aspect of the present invention, the present inventors have found that if the tubular portion of the shaft is made of an electrically conductive material and a window is formed in that tubular portion, then a simple and effective probe can be made by electrically insulating the rim of the window and then placing an electrode within the insulated window. This configuration allows the construction of a bipolar electrode having a simple and low cost design.


Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:

    • a) a hollow shaft having an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and a first window extending transversely through the annular wall and defining an inside rim, and
    • b) a first electrode disposed within the window and being in electrical connection with a power supply, and c) an electrically insulating material disposed between the inside rim of the first window and the first electrode.


Also in accordance with the present invention, there is provided an electrosurgical device, comprising:

    • a) a hollow shaft made of an electrically conductive material having an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and a first window extending transversely through the annular wall, and
    • b) a first electrode disposed within the window and being in electrical connection with a power supply.


In some embodiments, both the return and active electrodes are housed within the same window, thereby further reducing the complexity of the manufacturing process.


Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:

    • a) a hollow shaft having an annular wall having a longitudinal bore therein, a proximal portion and a distal portion, and a first window extending transversely through the annular wall, and
    • b) an active electrode disposed within the window and being in electrical connection with a power supply, and
    • a return electrode disposed within the window and being in electrical connection with the power supply.





DESCRIPTION OF THE FIGURES


FIG. 1 discloses a side view of a device of the present invention having a pair of complementary electrodes housed within a window and electrically isolated from the inside rim of the window by an insulating material.



FIG. 2 discloses a side view of a device of the present invention having a single electrode housed within a window and electrically isolated from the inside rim of the window by an insulating material.



FIG. 3 discloses a side view of a device of the present invention having a pair of electrodes traversing the diameter of the shaft and housed within opposing windows.



FIG. 4 discloses a side view of the present invention having a plurality of electrodes housed within a plurality of windows.



FIG. 5
a discloses a side view of a device of the present invention in which the device has been longitudinally cross-sectioned to reveal nesting features.



FIG. 5
b discloses an exploded view of FIG. 5a.



FIG. 6 discloses a cross-sectional view of a device of the present invention having a grooved distal tip and a crimped shaft.



FIG. 7 discloses a cross-sectional view of a device of the present invention having a throughhole traversing the distal tip and shaft and filled with a bonding material.



FIGS. 8
a and 8b disclose distal tips of the present invention having chamfered features.



FIGS. 9
a-f disclose a circular transverse cross-sections of the sharp tip.



FIG. 10 discloses a device of the present invention having a means for delivering fluid that delivers fluid through an opening on the surface of the distal tip.



FIG. 11 discloses a device of the present invention having a means for delivering fluid that delivers fluid through an opening on the surface of the insulating spacer.



FIG. 12
a discloses a device of the present invention having a means for delivering fluid that delivers fluid through a plurality of openings on the surface of the insulating spacer.



FIG. 12
b discloses a transverse cross section of FIG. 12a, taken through the spacer.



FIGS. 13
a-b are cross-sections of devices of the present invention having slidable temperature probes.



FIG. 13
c is a cross-section depicting various preferred locations for a temperature probe of a device of the present invention.



FIGS. 14
a-b are cross-sections of devices of the present invention having multi-sensor temperature probes.



FIG. 15
a is a cross-section of a device of the present invention having radially segmented electrodes.



FIG. 15
b is a side view of a device of the present invention having axially segmented electrodes.



FIG. 16 is a side view of a device of the present invention having slidable electrodes.



FIG. 17 is a side view of a device of the present invention in which both the tip and shaft of the device are return electrodes.



FIGS. 18
a and 18b present axial and transverse cross-sectional views of an embodiment of the present invention in which the electrode surfaces are configured to allow current to flow out of only one side of the device.



FIGS. 19
a and 19b present axial cross-sectional views of a telescoping embodiment of the present invention in which the electrodes are in respective undeployed and deployed configurations.





DETAILED DESCRIPTION OF THE INVENTION

For the purposes of the present invention, the “resistive heating zone” is the zone of bone tissue that is resistively heated due to an energy loss incurred by current traveling directly through the bone tissue. Resistive heating, “joule” heating and “near-field” heating may be used interchangeably herein. The “conductive heating zone” is the zone of bone tissue that is heated due to the conduction of heat from an adjacent resistive heating zone. The total heating zone (“THZ”) in a bone tissue includes both the resistive heating zone and the conductive heating zone. The border between the conductive and resistive heating zones is defined by the locations where the strength of the electric field is 10% of the maximum strength of the electric field between the electrodes. For the purposes of the present invention, the heating zones encompass the volume of bone tissue heated to at least 42° C. by the present invention. For the purposes of the present invention, the “first and second sides” of a vertebral body are the lateral-lateral sides intersected by the basivertebral nerve (“BVN”).


Preferably, the present invention comprises a novel probe adapted for piercing cortical bone and having a novel bipolar electrode configuration. More preferably, the present invention comprises a sharp stainless steel tip of sufficient sharpness to pierce cortical bone that is welded to one end of a hollow stainless steel shaft (or, “hypotube”). More preferably, a slot or window is cut into the distal portion of the shaft, thereby providing a window into which insulated electrodes can be placed. The insulation of the electrodes can be accomplished by providing an insulating material, such as a plastic insert or a potted encapsulant, between the inner rim of the window and the electrode.


This design is advantageous over conventional designs because it provides a relatively inexpensive device that is sufficiently rigid and strong to pierce cortical bone, thereby allowing its use for treating osseous nerves and bone tumors within the bone.


In some embodiments, the outer metal shaft of the inventive probe can be coated with an electrical insulator, such as PTFE to electrically insulate the shaft from the body tissue.


In another embodiment of the present invention, there is provided a radiofrequency (RF) applicator device (or “probe”) comprising a hollow rigid tube (such as stainless steel) fitted with a handle at its proximal end and an insulating spacer at its distal end, wherein a portion of the insulating spacer is nested within the distal end of the hollow tube. The proximal end of a distally disposed sharp tip is then nested through the spacer and into the distal end of the hollow tube, thereby imparting electrical isolation and greater strength to the assembled device. Preferably, the hollow tube is adapted to be a first electrode and the tip is adapted to be a second electrode, thereby forming a bipolar heating device adapted for treating hard tissue. Preferably, the device may optionally include channels or ports through which a conductive fluid, such as saline, can be delivered to the heating zone to improve the efficiency of the device.


Now referring to FIG. 1, there is provided an electrosurgical device 1, comprising:

    • a) a hollow shaft 3 having an annular wall having a longitudinal bore therein, a proximal portion 9 and a distal portion 11, and a first window extending transversely through the annular wall and forming a rim 15, and
    • b) an active electrode 21 disposed within the window and being in electrical connection with a power supply via first lead 23,
    • c) a return electrode 31 disposed within the window and being in electrical connection with the power supply via second lead 33,
    • d) an electrically insulating material 61 disposed between the inside rim of the window and the first electrode,
    • e) a tip 51 having a solid proximal end 53 and a sharp tipped distal end 55 adapted to penetrate cortical bone, the proximal end of the tip being mechanically connected to the distal portion of the bore of the hollow shaft,
    • f) an outer insulating shell 71 surrounding the proximal portion of the hollow shaft,
    • g) a thermocouple 81 disposed within the electrically insulating material and being in electrical connection with a digital thermometer via third pair of leads 83.


The shaft of the present invention preferably comprises a hollow tube that allows at least one lead wire to be run therethrough. The material selection and dimensions of the shaft should be selected so as to allow the shaft to support the penetration of the cortical bone by the tip without yielding. Typically, the shaft is made of a metallic or ceramic material. Preferably, the shaft is made of a conductive material, such as a metal. Preferably, the metallic shaft material is selected from the group consisting of stainless steel, titanium, titanium-containing alloys, such as nitinol, copper, and copper plated with gold or platinum. More preferably, the metallic shaft material is stainless steel. In some embodiments, the shaft has a length of between 3 and 20 cm (preferably between 5 cm and 12 cm, an inner diameter of between 0.5 and 5 mm (preferably between 5 and 3 mm), and an outer diameter of between 1 and 6 mm (preferably between 2.0 and 4 mm). When the dimensions of the shaft are within these ranges, conventional biomaterials such as stainless steel can be suitably used.


In some embodiments, the proximal end of the spacer is received over the distal end of the shaft.


The function of the electrodes of the present invention is to be in direct contact with tissue and provide a pathway for RF current through a portion of the tissue surrounding the probe, thereby therapeutically heating the tissue. The electrodes are typically made of metals, such as stainless steel, platinum, gold, copper (nickel-plated or gold-plated), platinum, or a conductive polymer (such as a carbon- or silver-filled epoxy). Preferably, the electrode material of construction is such that its coefficient of thermal expansion is within 50% of the coefficient of thermal expansion of the material selected as the insulator 61.


The function of the insulating annulus of the present invention is to electrically insulate the electrodes located within the window from the electrically conductive shaft. The insulating annulus is typically made of PTFE, nylon, an epoxy, a polyurethane, a polyimide, or other suitable polymer, or a ceramic material.


Preferably, tip 51 provides two functions. First, its sharp tipped distal end 55 should be sufficiently pointed to penetrate cortical bone. Accordingly, although angle α may be any angle between about 0 degrees and about 90 degrees, angle α is preferably between 20 and 70 degrees. When the tip angle is below this range, the tip may be fragile and may be susceptible to breaking during cortical rim penetration. When the angle is above this range, the tip is too blunt and may require excessive force to achieve cortical rim penetration. In some embodiments, the proximal portion of the tip is solid, thereby providing additional strength to the tip. In some embodiments, the proximal portion of the tip has a diameter that substantially the same as the outer diameter of the shaft. In this condition, the proximal portion of the tip may be mechanically joined to the distal end of the shaft (for example, by welding) to produce a strong, streamlined probe.


In other embodiments, the sharp tipped distal end is formed near the axial center of the tip to produce a conical shape.


In some embodiments, the device further comprises an outer insulating sleeve (such as sleeve 71) surrounding at least the proximal portion of the hollow shaft. The function of the sleeve is to electrically isolate the device from the tissue that is adjacent the target tissue, thereby increasing the safety and effectiveness of the device. In some embodiments, the material of construction for the sleeve is selected from the group consisting of polymeric materials such as PTFE and ceramic materials such as alumina. In some embodiments, the sleeve is provided in the form of a coating upon the shaft. In other embodiments, the sleeve is manufactured separately and slid over the shaft. Typically, the sleeve has a length that is between 50% and 95% of the length of the shaft length. In some embodiments, the sleeve extends distally towards the window and terminates within one length of the window.


In some embodiments, the thermocouple is coupled to the power supply in a feedback loop to modulate the power output and thereby control the temperature at the tip.


Now referring to FIG. 2, in other embodiments, the device of FIG. 1 could be modified so that shaft window 213 houses only a single electrode 221. In this instance, the conductive shaft could be electrically connected to the power supply via a handle (not shown) to become the second electrode 223 of a bipolar design. The advantage of having only a single electrode within the window is that the area of the window can be decreased, thereby enhancing the strength of the shaft. When only a single electrode is located within the window, the surface area of that electrode is generally between 0.5 and 20 mm2. This is advantageous in applications requiring relatively larger surface area electrodes. In such embodiments, this embodiment can capably accommodate the larger surface area electrode without increasing window area. In some embodiments, the single windowed electrode could be the active electrode, while in others it could be the return electrode. In some embodiments, the single windowed electrode is the active and has a surface area of between 0.5 and 20 mm2.


In this configuration, the placement of an insulating sleeve preferably provides a distal uninsulated portion of the shaft having a length of between 3 mm and 20 mm, and is more preferably about 5 mm. In preferred embodiments thereof, the insulation is selected from the group consisting of polyimide tape, PTFE tape, and heat shrink tubing. One preferred thickness of the insulation ranges from about 0.006 mm to about 0.012 mm) (i.e., about 0.00025 to 0.0005 inches), and is provided by a dielectric coating, such as a polyimide coating.


Now referring to FIG. 3, in other embodiments, the device of FIG. 1 could be modified to include a pair of windows 313,315 located on opposite sides of the shaft. In such an embodiment, the electrodes 321,323 and insulator 361 could be modified to essentially traverse the bore and connect the windows. This embodiment advantageously allows the clinician to treat target zones on either side of the device, and so is advantageous in instances in which the device is placed within a target tissue such as a tumor.


Alternatively, in some embodiments, neither electrode completely traverses the transverse width of the tube. In some embodiments thereof, each electrode opens through a window on the same side of the tube. In other embodiments thereof, a first electrode opens through a first window on a first side of the tube, and a second electrode opens through a second window on a second side of the tube, preferably on a diametrically opposed side of the tube.


Now referring to FIG. 4, in other embodiments, the device of FIG. 1 could be modified to include a plurality of windows 413, 415, 417 spaced along the length of the shaft, wherein each window has at least one electrode 423, 425, 427 located therein. Each of these windows is electrically isolated from the conductive shaft by an insulating annulus 461, 463, 465. The provision of multiple windowed electrodes allows the surgeon the ability to either treat different zones at different times without needing to move the device, or to treat a larger area. In some embodiments having a series of windows (not shown), both the return and active electrodes can be located within the same window. In other embodiments, each window houses a single (preferably, active) electrode, and the second (preferably, return) electrode 433,435,437 is provided on the surface of the electrically conductive shaft between bands of insulating material. In other embodiments, the second return electrode is provided by another windowed electrode. Thus, the surgeon can select any pair of electrode to define the treatment area. In this particular embodiment, return electrode 433 is electrically connected to the power supply via an internal lead (not shown) and is electrically isolated from the remainder of the shaft by insulating windows comprising left side portion 491 and right side portion 493.


In some embodiments, and now referring to FIGS. 5a and 5b, an intermediate spacer 591 is provided between the shaft 511 and the sharp tip 521. When this spacer is made of an electrically insulating material, the sharp tip 521 could be adapted to function as the first electrode. In some embodiments thereof, the shaft 511 could be adapted to function as the second electrode. The use of the tip and shaft as paired electrodes is advantageous because of its simplicity of design and assembly, and its larger active surface area.


In some embodiments, as in FIGS. 5a and 5b, the insulating spacer is hollow. The hollow nature of the spacer allows a lead wire to run therethrough and electrically connect the sharp tip to the power supply, and also allows the proximal end 523 of the tip to be nested in the hollow distal portion 595 of the spacer. In these FIGS. 5a and 5b, the proximal end portion 593 of the hollow spacer is nested within the distal end portion 513 of the conductive shaft.


The robust nature of the embodiment shown in FIG. 5a could be further enhanced by proximally extending the nested portion of the hollow spacer sufficiently deep into the distal portion of the shaft, thereby providing increased surface area for bonding.


Similarly, the proximal end portion 523 of the sharp tip (the distal half 525 of which is preferably solid) can be made to extend so far proximally as to nest in the conductive shaft. Because the intervening spacer is made of an electrically insulating material, the conductive tip is electrically isolated from the conductive shaft. The proximal extension of the tip into the shaft likewise increases the robust nature of the probe.


Now referring to FIG. 6, the robust nature of the probe could be further fortified to prevent tip pull-out by providing a circumferential groove 601 in the nested portion of the solid tip and providing a swage or crimp 603 in the portion of the outer shaft overlying the groove. In such embodiments, the intervening insulating spacer should be made of a material sufficiently malleable to accept crimping or swaging.


Now referring to FIG. 7, the robust nature of the probe could be further fortified to prevent tip pull-out by providing a transverse through-hole 701 through the probe in the area of the nested portion of the solid tip and then filling the throughhole with a bonding material such as an adhesive such as epoxy, or with an electrically non-conductive locking pin or screw.


Now referring to FIG. 8a, in some embodiments, it may be desirable to provide a tapered feature 801 upon the distal end of the sharp tip. Providing such a tapered feature is advantageous because a) it will prevent the device from penetrating through the anterior cortical wall of the vertebral body, and b) it will reduce current density at the electrode tip and minimize regions of excessive current density, thereby providing an even heating zone. In some embodiments, as in FIG. 8a, the tapered feature comprises a chamfer. In others, as in FIG. 8b, the tapered feature is more substantial and preferably comprises an essentially 180 degree rounded curve, such as a semicircle or a bullet nose 803.


Now referring to FIGS. 9a-9f, in some embodiments, the transverse cross section of the sharp tip is acircular. The acircular cross-section may allow the clinician to generate differently shaped heating profiles, or to access different anatomies (such as between tissue planes, or to follow specific tissue contours (i.e., between the intervertebral disc and spinal cord). In some preferred embodiments, the acircular cross section is selected from the group consisting of rounded (as in FIG. 9a), oval (as in FIG. 9b), elliptical (as in FIG. 9c), bilobular (as in FIG. 9d), arc-like (as in FIG. 9e) and s-shaped (as in FIG. 9f).


If the active electrode has no active cooling means, it may become be subject to conductive heating induced by the heated tissue, and the resultant increased temperature at the electrode-tissue interface in the electrode may adversely affect performance by charring the adjacent bone tissue. Accordingly, in some embodiments, a cool tip active electrode may be employed. The cooled electrode helps maintain the temperature of the electrode at a desired temperature. Cooled tip active electrodes are known in the art. Alternatively, the power supply may be designed to provided a pulsed energy input. It has been found that pulsing the current favorably allows heat to dissipate from the electrode tip, and so the active electrode stays relatively cooler.


In some embodiments, and now referring to FIG. 10, it may also be desirable to provide a means for delivering a fluid to the distal end of the device. The fluid may be a cooling fluid that will help control the heating activity, or it may be a carrier for therapeutic agents such as drugs, or provide an electrolyte solution (such as isotonic or hypertonic saline) for efficient current flow. In some embodiments, providing the means for delivering a fluid could be accomplished by providing a longitudinal fluid delivery tube 1001 extending from the tubular portion of the shaft to the outer surface 1003 of either the sharp tip 1005 or insulating spacer 1007. Preferably, the fluid delivery tube has a proximal portion 1011 extending into the tubular portion of the shaft and a distal portion 1013 opening onto the outer surface 1015 of the sharp distal tip.


In some embodiments, as in FIG. 10, the fluid delivery tube is provided as a separate physical entity. In other embodiments, the fluid delivery tube is made by simply providing longitudinal, fluidly connected holes in the other components.


Now referring to FIG. 11, in some embodiments in which the sharp tip 1113 also acts as an electrode, the fluid delivery tube 1101 has a proximal portion 1103 extending into the tubular portion 1105 of the shaft and a distal opening portion 1109 opening onto the outer surface 1111 of the insulating spacer. In these embodiments, the spacer acts not only as a conduit for fluid delivery, it still provides electrical insulation between the sharp tip electrode and the shaft-based electrode. In some embodiments, as in FIG. 11, the fluid delivery tube can comprise a separate physical entity portion 1115 and a portion 1117 produced by making a hole in an already existing component (such as spacer 1121).


Now referring to FIG. 12a, in some embodiments, multiple fluid delivery tubes 1201, 1203 are used. In these embodiments, conductive efficiency is enhanced because the multiple fluid delivery tubes may now deliver fluid all about the radius of the device, as shown in cross-sectional FIG. 12b. FIG. 12b is a cross-section of FIG. 12 a taken transversely through the spacer. In FIG. 12b, longitudinal hole portions 1251 are provided between the inner 1253 and outer 1255 diameters of the spacer to deliver fluid from within the shaft, while radially extending hole portions 1257 extend radially from the longitudinal hole portions and deliver fluid to the outer surface 1259 of the spacer 1261.


In some embodiments, thermocouples are placed in radially extending hole portions of the fluid delivery tubes in order to monitor the surface temperature of the device at various radial locations. In these embodiments, the fluid delivery tube having a thermocouple therein is effectively blocked so that each tube has either a thermocouple or fluid delivery function, but not both.


Also as shown in this embodiment, the proximal portion 1211 of each fluid delivery tube can comprise a single inner wall 1213 and a single outer wall 1215 defining a single large diameter annulus 1217 therebetween. Fluid is delivered through this annulus to the proximal portion 1219 of the plurality of holes 1221 provided in the insulating spacer.


The annular nature of the proximal portion of the fluid delivery tube is also advantageous because it also provides a convenient inner tube 1223 through which a lead 1225 can be run to electrically connect the sharp tip 1227 to the power supply.


In general, it is desirable to operate the present invention in a manner that produces a peak temperature in the target tissue of between about 80° C. and 100° C. When the peak temperature is below 80° C., the off-peak temperatures may quickly fall below about 45° C. When the peak temperature is above about 100° C., the bone tissue exposed to that peak temperature may experience necrosis and charring. This charring reduces the electrical conductivity of the charred tissue, thereby making it more difficult to pass RF current through the target tissue beyond the char and to resistively heat the target tissue beyond the char. In some embodiments, the peak temperature is preferably between 90° C. and 98° C.


It is desirable to heat the volume of target tissue to a minimum temperature of at least 42° C. When the tissue experiences a temperature above 42° C., nerves within the target tissue may be desirably, damaged. However, it is believed that denervation is a function of the total quantum of energy delivered to the target tissue, i.e., both exposure temperature and exposure time determine the total dose of energy delivered. Accordingly, if the temperature of the target tissue reaches only about 42° C., then it is believed that the exposure time of the volume of target tissue to that temperature should be at least about 30 minutes and preferably at least 60 minutes in order to deliver the dose of energy believed necessary to denervate the nerves within the target tissue.


Preferably, it is desirable to heat the volume of target tissue to a minimum temperature of at least 50° C. If the temperature of the target tissue reaches about 50° C., then it is believed that the exposure time of the volume of target tissue to that temperature need only be in the range of about 2 minutes to 10 minutes to achieve denervation.


More preferably, it is desirable to heat the volume of target tissue to a minimum temperature of at least 60° C. If the temperature of the target tissue reaches about 60° C., then it is believed that the exposure time of the volume of target tissue to that temperature need only be in the range of about 0.5 minutes to 3 minutes to achieve denervation, preferably 1 minute to 2 minutes.


Typically, the period of time that an intraosseous nerve (“ION”) is exposed to therapeutic temperatures is in general related to the length of time in which the electrodes are at the target temperature following heat up. However, since it has been observed that the total heating zone remains relatively hot even after power has been turned off (and the electric field eliminated), the exposure time can include a period of time in which current is not running through the electrodes.


In some embodiments, it is desirable to heat the target tissue so that at least about 1 cm3 of bone tissue experiences the minimum temperature. This volume corresponds to a sphere having a radius of about 0.6 cm. Alternatively stated, it is desirable to heat the target tissue so the minimum temperature is achieved by every portion of the bone within 0.6 cm of the point experiencing the peak temperature.


More preferably, it is desirable to heat the target tissue so that at least about 3 cm3 of bone experiences the minimum temperature. This volume corresponds to a sphere having a radius of about 1 cm.


In one preferred embodiment, the present invention provides a steady-state heated zone having a peak temperature of between 80° C. and 100° C. (and preferably between 90° C. and 98° C.), and heats at least 1 cm3 of bone (and preferably at least 3 cm3 of bone) to a temperature of at least 50° C. (and preferably at least 60° C.).


As noted above, a peak temperature below about 100° C. is desirable in order to prevent charring of the adjacent tissue, steam formation and tissue popping. In some embodiments, this is accomplished by providing the power supply with a feedback means that allows the peak temperature within the heating zone to be maintained at a desired target temperature, such as 90-98° C. In some embodiments, between about 10 watts and 30 watts of power is first supplied to the device in order to rapidly heat the relatively cool bone, with maximum amperage being obtained within about 10 15 seconds. As the bone is further heated to the target temperature, the feedback means gradually reduces the power input to the device to between about 6 10 watts.


Although preferred embodiments of the present invention typically comprises bipolar electrodes, the probes of the present invention can be easily adapted to provide monopolar use. For example, the device of FIG. 2 could be modified so that the shaft is electrically isolated at the handle, and a ground electrode is provided to extend from the power supply to the patient.


The following section relates to the general structure of preferred energy devices in accordance with the present invention:


The apparatus according to the present invention comprises an electrosurgical probe having a shaft with a proximal end, a distal end, and at least one active electrode at or near the distal end. A connector is provided at or near the proximal end of the shaft for electrically coupling the active electrode to a high frequency voltage source. In some embodiments, a return electrode coupled to the voltage source is spaced a sufficient distance from the active electrode to substantially avoid or minimize current shorting therebetween. The return electrode may be provided integral with the shaft of the probe or it may be separate from the shaft.


In preferred embodiments, the electrosurgical device will comprise a shaft or a handpiece having a proximal end and a distal end which supports one or more electrodes. The shaft may assume a wide variety of configurations, with the primary purpose being to mechanically support the active electrode and permit the treating physician to manipulate the electrode from a proximal end of the shaft. The shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode array. The shaft may include a plurality of wires or other conductive elements running axially therethrough to permit connection of the electrode array to a connector at the proximal end of the shaft.


In some embodiments, the shaft comprises a hollow annulus adapted to be introduced through a posterior percutaneous penetration in the patient. Thus, the shaft adapted for posterior percutaneous use may have a length in the range of about 3 to 25 cm (preferably, 12-15 cm), and a diameter in the range of about 1 mm to about 6 mm (preferably, 2-5 mm). However, for endoscopic procedures within the spine, the shaft will have a suitable diameter and length to allow the surgeon to reach the target site (e.g., a disc) by delivering the shaft through the thoracic cavity, the abdomen or the like. Thus, the shaft may have a length in the range of about 5.0 to 30.0 cm, and a diameter in the range of about 1 mm to about 6 mm (preferably, about 2 mm to about 4 mm). In any of these embodiments, the shaft may also be introduced through rigid or flexible endoscopes.


The probe further comprises one or more active electrode(s) for applying electrical energy to the cancellous region of the vertebral body. The probe may be bipolar and include one or more return electrode(s). In some embodiments thereof, the bipolar probe has an active electrode array disposed at its distal end. In other embodiments, the probe may be monopolar, whereby the return electrode may be positioned on the patient's back, as a dispersive pad. In either embodiment, sufficient electrical energy is applied through the probe to the active electrode(s) to heat the tissue in the target area and thereby denervate at least a portion of the basivertebral nerve within the vertebral body.


In some embodiments, the probe that is delivered percutaneously and/or endoluminally into the patient by insertion through a conventional or specialized guide catheter. The catheter shaft may include a guide wire for guiding the catheter to the target site, or the catheter may comprise a steerable guide catheter. The catheter may also include a substantially rigid distal end portion to increase the torque control of the distal end portion as the catheter is advanced further into the patient's body.


In some embodiments, the electrically conductive wires may run freely inside the catheter bore in an unconstrained made, or within multiple lumens within the catheter bore.


In some embodiments, the tip region of the device may comprise many independent electrode terminals designed to deliver electrical energy in the vicinity of the tip. The selective application of electrical energy is achieved by connecting each individual electrode terminal and the return electrode to a power source having independently controlled or current limited channels. The return electrode(s) may comprise a single tubular member of conductive material proximal to the electrode array. Alternatively, the instrument may comprise an array of return electrodes at the distal tip of the instrument (together with the active electrodes) to maintain the electric current at the tip. The application of high frequency voltage between the return electrode(s) and the electrode array results in the generation of high electric field intensities at the distal tips of the electrode terminals with conduction of high frequency current from each individual electrode terminal to the return electrode. The current flow from each individual electrode terminal to the return electrode(s) is controlled by either active or passive means, or a combination thereof, to deliver electrical energy to the surrounding conductive fluid while minimizing energy delivery to surrounding (non-target) tissue.


In some embodiments, the device further comprises at least one temperature probe. The temperature is preferably selected from the group consisting of a thermocouple, a thermistor, and a fiber-optic probe (and is preferably a thermocouple). Thermocouples associated with the device may preferably be disposed on or within the electrode carrier; between the electrodes (preferred in bipolar embodiments); or within the electrodes (preferred for monopolar embodiments). In some embodiments wherein the electrodes are placed on either side of the basivertebral nerve, a thermocouple is disposed between the electrodes or in the electrodes. In alternate embodiments, the deployable portion of the thermocouple comprises a memory metal.


One common characteristic of conventional thermal therapy devices is the dimensionally fixed nature of the temperature probe. Because of this fixed nature, the temperature probe can not be moved relative to the shaft, and so can not provide spatially-changing analysis unless the shaft is moved as well. Because it is often problematic to move the shaft, the fixed nature of the probe limits the extent of temperature analysis.


Now referring to FIG. 13a, in one aspect of the present invention, there is provided a thermal therapy device 1301 having a sliding temperature probe. An axial bore 1303 is provided in the shaft 1306 of the present invention, and an elongate carrier 1305 having a probe 1307 disposed thereon is placed within the bore for slidable movement within the bore. Because the carrier is slidable, the temperature probe may be moved to different axial locations along the axis of the shaft by simply pushing or pulling the proximal end portion 1321 of the carrier, thereby providing the clinician with the ability to easily measure temperature at any selected axial location. In this particular instance, the distal end of the shaft has an opening 1311, thereby allowing the probe to record temperatures outside of the shaft.


Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:

    • a) a hollow shaft having an annular wall having an outer surface and a longitudinal bore therein, the longitudinal bore being in communication with an opening upon the outer surface,
    • b) a first electrode disposed on or within the shaft and being in electrical connection with a power supply, and
    • c) a thermal probe having a elongate carrier and a thermal sensor disposed on the carrier, wherein the carrier is slidably disposed within the longitudinal bore.


Although the device of FIG. 13a is useful in providing temperature information along the shaft axis, it can not provide off-axis information. Accordingly, in one preferred embodiment of the slidable probe, and now referring to FIG. 13b, the carrier 1311 is made of a memory metal material. As before, an axial bore is provided in the proximal portion of the shaft. However, in this embodiment, while the proximal portion 1313 of the bore is linear, the distal portion 1315 of the bore curves to open onto the surface of the shaft through opening 1317, thereby providing a curved bore. An elongate carrier 1311 made of a memory metal having a probe 1319 disposed thereon is placed within the bore for slidable movement within the bore. Because the carrier is made of a memory metal, the temperature probe may be moved to different off-axis locations by simply pushing or pulling the proximal end portion 1321 of the carrier, thereby providing the clinician with an even greater ability measure temperature radially around the device. In some embodiments, the temperature probe 1319 of FIG. 13b is located at the edge of the target zone to insure that the targeted zone is sufficiently dosed.


The temperature probe shown in FIG. 13a is located along the central axis of the shaft of the device. Although this central axial location provides ease of manufacture, the ability of the probe to record the actual tissue temperature may be diminished due to the fact that the probe is not actually in the tissue, but rather in he center of the therapeutic device.


Therefore, is some embodiments of the present invention, there is provided a thermal therapy device 1331 having an axially-offset temperature probe. Now referring to FIG. 13c, there are provided i) a first temperature probe A located within the central axis of the shaft; ii) a second temperature probe B located within the outer wall of the shaft; iii) a third temperature probe C located on the outer surface of the wall of the shaft (i.e., at the wall/tissue interface); and iv) a fourth temperature probe D located on the outer surface of the wall and at the electrode/insulator interface.


Locating the probe a position A allows the device to be easily manufactured. Locating temperature probe B located within the outer wall of the shaft allows the device to be easily manufactured and durable, and avoids biocompatibility issues. Locating third temperature probe C at the wall/tissue interface provides the most realistic estimate of the tissue temperature. Locating fourth temperature probe D at the electrode/insulator interface allows the device to be easily manufactured a provides measurement of a relatively hot region.


In general, bipolar and monopolar electrodes are used to apply a thermal therapy to tissue for a therapeutic effect. Many probes are actively temperature controlled to monitor and apply a certain thermal dose. Also, electrodes are often cooled (internally) to prevent charring near or on the probe tip and thus allow more power to hear tissue further away from the tip and to create a larger treatment zone. One major drawback to this type of device is that the system is not able monitor the temperature of the lesion. It only monitors the tip temperature, which is being cooled to 0° C., to allow more power to be put into the tissue and create a larger lesion.


In one embodiment of the present invention, and now referring to FIG. 14a, there is provided a thermal therapy device 1401 having a multi-sensor temperature probe comprising a carrier 1403 and a plurality of temperature sensors 1405, 1407 that deploys into the tissue to monitor heating and thermal dose directly distal of the tip. In some embodiments, a sensor 1409 is also provided on the carrier to monitor temperatures in the vicinity of the electrodes 1411. In use, once the device is placed in the tissue, the linear multisensor temperature probe is deployed away from the surface of the probe. Preferably, adjacent multisensors such as 1405 and 1407 are placed about 5 mm apart from each other to give adequate data for temperature distribution within the tissue.


Now referring to FIG. 14b, there is provided a multisensor temperature probe as in FIG. 14a, but the carrier is made of a memory metal, thereby allowing the carrier to deploy from a side wall of the shaft and allowing the clinician to record off-axis temperature data simultaneously from sensors 1415, 1417, 1419 and 1421 at a plurality of different locations.


The electrode terminal(s) are preferably supported within or by an insulating support positioned near the distal end of the device. The return electrode(s) may be located on the instrument shaft, on another instrument, or on the external surface of the patient (i.e., a dispersive pad). The return electrode is preferably integrated with the shaft. The proximal end of the shaft preferably includes the appropriate electrical connections for coupling the return electrode(s) and the electrode terminal(s) to a high frequency power supply, such as an electrosurgical generator.


In some embodiments, the distal end of the device has surface geometries shaped to promote the electric field intensity and associated current density along the leading edges of the electrodes. Suitable surface geometries may be obtained by creating electrode shapes that include preferential sharp edges, indented grooves, or by creating asperities or other surface roughness on the active surface(s) of the electrodes. Surface shapes according to the present invention can include the use of formed wire (e.g., by drawing round wire through a shaping die) to form electrodes with a variety of cross-sectional shapes, such as square, rectangular, L or V shaped, or the like. Edges may also be created by removing a portion of the elongate metal shaft to reshape the cross-section. For example, material can be ground along the length of a round or hollow shaft electrode to form D or C shaped electrodes, respectively, with edges facing in the cutting direction. Alternatively, material can be removed at closely spaced intervals along the shaft length to form transverse grooves, slots, threads or the like along the electrodes. In other embodiments, the shaft can be sectored so that a given circumference comprises an electrode region and an inactive region. In some embodiments, the inactive region is masked.


The return electrode is preferably spaced proximally from the active electrode(s) a suitable distance. In most of the embodiments described herein, the distal edge of the exposed surface of the return electrode is spaced about 2 to 25 mm from the proximal edge of the exposed surface of the active electrode(s). This distance may vary with different voltage ranges, the electrode geometry and depend on the proximity of tissue structures to active and return electrodes. The return electrode will typically have an exposed length in the range of about 1 to 20 mm. Preferably, the ratio of the exposed length of the return electrode to the active length of the active electrode is at least 2:1.


The present invention may use a single active electrode terminal or an array of electrode terminals spaced around the distal surface of the shaft. In the latter embodiment, the electrode array usually includes a plurality of independently current-limited and/or power-controlled electrode terminals to apply electrical energy selectively to the target tissue while limiting the unwanted application of electrical energy to the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive fluids, such as blood, normal saline, and the like. The electrode terminals may be independently current-limited by isolating the terminals from each other and connecting each terminal to a separate power source that is isolated from the other electrode terminals. Alternatively, the electrode terminals may be connected to each other at either the proximal or distal ends of the shaft to form a single wire that couples to a power source. Alternatively, different electrode terminals can be selected to be active, thereby modifying the path of current and subsequent lesion size and location.


In some embodiments, the plurality of active electrodes are radially staggered about the cross-section of the shaft. In some embodiments, the radially staggered electrodes are individually controllable.


Now referring to FIG. 15a, there is provided a transverse cross-sectional view of a device of the present invention having a preferred active electrode configuration. This configuration alternates the active electrodes 1501, 1507, 1513, 1515 between insulating elements 1505, 1511, 1509, 1503. The electrodes could be connected such that 1513 was active and the grouping of 1515, 1507 and 1501 was connected to the return of the RF source. This would influence the heating pattern as shown in FIG. 15a. Other modes of operation would be to connect 1513 to active and 1501 to return, or 1513 and 1501 to active and 1507 and 1515 to ground. Any of several connections will allow for slight changes in the heating pattern HP. In addition, the active electrodes could be multiplexed in time such that 1513 and 1501 would be connected to active and return, respectively for 1 to 10 seconds and then 1515 and 1507 would be connected to active and return for 1 to 10 seconds. In this way, the heating pattern can be manipulated to provide longer heating times for selected combinations, thereby increasing the temperature of the targeted tissue. The electrodes could also be made operational in a monopolar fashion, such that an electrode (i.e., 1515 or 1501) would be active for a period of time and then another electrode would be switched on. Another embodiment would be to connect any combination of one, two, three or four electrodes to active and the return would be remote on the patient. Any of these combinations could also be multiplexed in time or have greater or lesser voltages to create more or less heating, respectively.


In some embodiments, the plurality of active electrodes are axially segmented along the axis of the shaft. Now referring to FIG. 15b, there is provided a side view of a preferred active electrode configuration of the present invention. In this configuration, there is provided axially alternating active electrodes 1521, 1523 between insulating elements 1525, 1527 and 1529. These elements could be activated by connecting 1521 to active and 1523 to return, of the generator means. If 1521 was of a larger surface area than 1523, more heating will occur around the small surface area electrode. In a monopolar setup, the electrodes could be operated separately whether by multiplexing each in time or by applying the same or different voltages to each electrode.


In one configuration, each individual electrode terminal in the electrode array is electrically insulated from all other electrode terminals in the array within the shaft, and is connected to a power source that is isolated from each of the other electrode terminals in the array or to circuitry that limits or interrupts current flow to the electrode terminal when a low resistivity material (e.g., blood) causes a lower impedance path between the return electrode and the individual electrode terminal. The isolated power sources for each individual electrode terminal may constitute separate power supply circuits having internal impedance characteristics that act to limit the supply of power to the associated electrode terminal when a low impedance return path is encountered. By way of example, the isolated power source may be a user-selectable constant current source. In this embodiment, lower impedance paths will automatically result in lower resistive heating levels since the heating is proportional to the square of the operating current times the impedance. Alternatively, a single power source may be connected to each of the electrode terminals through independently actuatable switches, or by independent current limiting elements, such as inductors, capacitors, resistors and/or combinations thereof. The current limiting elements may be provided in the shaft, connectors, cable, controller or along the conductive path from the controller to the distal tip of the device. Alternatively, resistance and/or capacitance may be provided on the surface of the active electrode terminal(s) by providing an oxide layer that forms selected electrode terminals (e.g., titanium or a resistive coating on the surface of metal, such as platinum).


In a preferred aspect of the invention, the active electrode comprises an electrode array having a plurality of electrically isolated electrode terminals disposed over a contact surface (which may be a planar or non-planar surface, and which may be located at the distal tip of the device or over a lateral surface of the shaft, or over both the tip and lateral surface(s)). The electrode array will include at least two and preferably more electrode terminals, and may further comprise a temperature sensor. In a preferred aspect, each electrode terminal will be connected to the proximal connector by an electrically isolated conductor disposed within the shaft. The conductors permit independent electrical coupling of the electrode terminals to a high frequency power supply and control system with optional temperature monitoring of the operation of the probe. The control system preferably incorporates active and/or passive current limiting structures, which are designed to limit current flow when the associated electrode terminal is in contact with a low resistance return path back to the return electrode.


The use of such electrode arrays in electrosurgical procedures is particularly advantageous as it has been found to limit the depth of tissue necrosis without substantially reducing power delivery. Since the shaft is hollow, a conductive fluid could be added through the annulus of the shaft and flow into the bone structure for the purposes of lowering the electrical impedance and filling the spaces in the cancellous bone to make the target tissue a better conductor.


Another characteristic of conventional thermal-therapy electrode devices is the dimensionally-fixed nature of the electrode. Because of this fixed nature, the electrode can not be moved relative to the shaft, and so can not provide spatially-changing therapy unless the shaft is moved as well. Because it is often problematic to move the shaft, the fixed nature of the electrode limits the extent of thermal therapy.


Now referring to FIG. 16, in one aspect of the present invention, there is provided a thermal therapy device 1601 having a sliding electrode. In one embodiment, the shaft 1602 comprises first 1603 and second 1605 elongate portions having a reduced diameter. These reduced diameter portions are separated by an intermediate shaft portion 1607 of the shaft having a larger diameter. First 1611 and second 1613 annular electrodes has bores dimensioned so as to be slidable within those reduced diameter sections so that when the electrodes are placed upon the reduced diameter sections, slidable movement within those reduced diameter sections is obtained. Because the electrode is slidable, the electrodes may be moved to different axial locations, thereby providing the clinician with the ability to easily change the heating pattern at any selected axial location.


In some embodiments, each of the sliding electrodes is moved towards intermediate portion 1607. This results in a smaller gap between the electrodes and consequently a more compact heating pattern.


In some embodiments, each of the sliding electrodes is moved away from intermediate portion 1607. This results in a larger gap between the electrodes and consequently a more elongated heating pattern. If the gap is sufficiently large, then the heating pattern may form two essentially separate zones adjacent to the electrodes.


In some embodiments, each of the sliding electrodes is moved in the same direction (i.e., distally). This results in a more distal heating pattern.


Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:

    • a) a shaft having:
      • i) an first outer surface having first and second portions having a first diameter, and
      • ii) a first reduced diameter outer surface located between the first and second portions having the first diameter,
    • b) a first annular electrode disposed on the reduced diameter outer surface of the shaft and dimensioned so as to be slidable upon the reduced diameter outer surface, the electrode being in electrical connection with a power supply.


Also in accordance with the present invention, there is provided a thermal therapy device comprising:

    • a) a shaft having:
      • i) an first outer surface having first, second and third portions having a first diameter, and
      • ii) first and second reduced diameter outer surface portions, the first being located between the first and second portions having the first diameter, and the second being located between the second and third portions having the first diameter,
    • b) a first and second annular electrodes disposed on the reduced diameter outer surface of the shaft and dimensioned so as to be slidable upon the respective first and second reduced diameter outer surfaces, each electrode being in electrical connection with a power supply so as to form and active and return electrode.


It should be clearly understood that the invention is not limited to electrically isolated electrode terminals, or even to a plurality of electrode terminals. For example, an array of active electrode terminals may be connected to a single lead that extends through the shaft to a power source of high frequency current. Alternatively, the device may incorporate a single electrode extending directly through the shaft or connected to a single lead that extends to the power source. The active electrode(s) may have a shape selected from the group consisting of a ball shape, a twizzle shapes, a spring shape, a twisted metal shape, a cone shape, an annular shape and a solid tube shape. Alternatively, the electrode(s) may comprise a plurality of filaments, rigid or flexible brush electrode(s), side-effect brush electrode(s) on a lateral surface of the shaft, coiled electrode(s) or the like.


The current applied between the return electrode(s) and the electrode terminal(s) is preferably a high or radio frequency current, typically between about 50 kHz and 20 MHz, usually being between about 100 kHz and 2.5 MHz, preferably being between about 400 kHz and 1000 kHz, often less than 600 kHz, and often between about 500 kHz and 600 kHz. The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 10 volts to 200 volts, often between about 20 to 100 volts depending on the electrode terminal size, the operating frequency and the operation mode of the particular procedure. Lower peak-to-peak voltages are preferred for thermal heating of tissue, and will typically be in the range from 100 to 1500, preferably 45 to 1000 and more preferably 45 to 80 volts rms. As discussed above, the voltage is usually delivered continuously with a sufficiently high frequency RF current (e.g., on the order of 50 kHz to 20 MHz) as compared with e.g., lasers that produce small depths of necrosis and are generally pulsed about 10 to 20 Hz. In addition, the sine wave duty cycle (i.e., cumulative time in any one-second interval that energy is applied) is preferably on the order of about 100% for the present invention, as compared with pulsed lasers which typically have a duty cycle of about 0.0001%.


The power source allows the user to select the power level according to the specific requirements of a particular procedure. The preferred power source of the present invention delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being heated, and/or the maximum allowed temperature selected for the device tip.


The power source may be current limited or otherwise controlled so that undesired heating of the target tissue or surrounding (non-target) tissue does not occur. In one embodiment of the present invention, current limiting inductors are placed in series with each independent electrode terminal, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in U.S. Pat. No. 5,697,909. Additionally, current limiting resistors may be selected. Preferably, microprocessors are employed to monitor the measured current and control the output to limit the current.


The area of the tissue treatment surface can vary widely, and the tissue treatment surface can assume a variety of geometries, with particular areas and geometries being selected for specific applications. The geometries can be planar, concave, convex, hemispherical, conical, linear “in-line” array or virtually any other regular or irregular shape. Most commonly, at least one of the active electrode(s) or electrode terminal(s) will be formed at the distal tip of the device, and is frequently planar, disk-shaped, or hemispherical. Alternatively or additionally, the active electrode(s) may be formed on lateral surfaces of the electrosurgical instrument shaft (e.g., in the manner of a spatula), facilitating access to certain body structures in endoscopic procedures.


The devices of the present invention may be suitably used for insertion into any hard or soft tissue in the human body, but are most advantageously used in hard tissue. In some embodiments, the hard tissue is bone. In other embodiments, the hard tissue is cartilage. In preferred embodiments when bone is selected as the tissue of choice, the bone is a vertebral body. Preferably, the present invention is adapted to puncture the hard cortical shell of the bone and penetrate at least a portion of the underlying cancellous bone. In some embodiments, the probe advances into the bone to a distance of at least ⅓ of the cross-section of the bone defined by the advance of the probe.


In some embodiments, there is provided a preferred procedure comprising a first step of penetrating the hard cortical bone with a sharp tipped biopsy needle housed in a cannula, and a second step of delivering a device of the present invention having a radiused or bullet nose through the cannula through the location of pierced bone.


In some embodiments, the present invention is practiced in vertebral bodies substantially free of tumors. In others, the present invention is practiced in vertebral bodies having tumors.


In some embodiments, the target region of the basivertebal nerve (BVN) is located within the cancellous portion of the bone (i.e., to the interior of the outer cortical bone region), and proximal to the junction of the BVN having a plurality of branches. Treatment in this region is advantageous because only a single portion of the BVN need be effectively treated to denervate the entire system. In contrast, treatment of the BVN in locations more downstream than the junction require the denervation of each branch.


In another embodiment, as in FIG. 17, the electrical connections between the device and the power supply can be configured so as to cause each of the tip and the shaft to become return electrodes that sandwich an active electrode.


In some embodiments of the present invention, the insulation and/or electrode geometries are selected to provide a more directional flow of current out of the device. In some embodiments, the electrode portions and insulating portions of the device are configured so that current flows through a hemi-cylindrical portion of a transverse cross-section of the device. For example, in some embodiments, as shown in FIGS. 18a and 18b, there is provided a device comprising a shaft 1801, a spacer 1803, and a tip 1805. The electrode portions 1807, 1809 and insulation portions 1811 of the device are configured so that current flows only across a first side 1813 of the device.


Although the embodiment shown in FIGS. 18a and 18b describes an active electrode surface of about 180°, other variations in the arc circumscribed by the active electrode surface are also contemplated (such as about 90°, about 270°).


In other embodiments, the active electrode surface area may change along the longitudinal axis, thereby varying the heating profile. For example, the active electrode surface may taper from a proximal 180° arc to a distal 90° arc.


In some embodiments, there is provided a device having a telescoping deployment of the electrodes. Now referring to FIGS. 19a and 19b, there is provided a device of the present invention having insulating portions 1901 and electrodes 1903, wherein the distal tip 1905 and the electrodes 1903 are mounted on an inner shaft 1907 contained within a hollow outer hollow shaft 1909 in a concentric telescoping manner, such that the distal tip and the electrodes of the inner shaft are deployable from the hollow outer shaft. FIG. 19a presents the device in an undeployed configuration, while FIG. 19b presents the device in a deployed configuration. In this embodiment, an electrode 1903 is located on the distal tip 1905 of the inner shaft.


In some embodiments, the hollow outer shaft contains one or more electrodes 1904 located on or near the distal end 1911 of the hollow outer shaft.


In some embodiments, deployment of the electrodes is carried out by a simple sliding motion.


In others, the inner portion of the outer shaft and the outer portion of the inner shaft comprise complementary threadforms, so that the relative rotation of one of the shafts causes linear distal displacement of the inner shaft. The mechanical advantage provided by this embodiment provides the clinician with an increased force and increased precision.


In another embodiment, the inner portion of the outer shaft and the outer portion of the inner shaft form a complementary pin-and-helical groove structure. This embodiment allows for a more rapid deployment of the electrodes to a fixed distal position.


Deployment mechanisms for these embodiments are well known in the art and are preferably located in part upon the proximal portion of a handle of the device.


This telescoping embodiment advantageously provides the surgeon with an ability to adjust the location of an electrodes without moving the entire probe. That is, the surgeon may treat a first location, adjust the location of the electrode by telescoping, and then treat a second location.


Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:

    • a) an outer shaft 1909 having i) a hollow bore 1921 defining an inner surface 1923 and an distal opening 1925, and ii) a first electrode 1904;
    • b) an inner shaft 1907 having i) an outer surface 1927 dimensioned so as to be axially movable within the bore of the outer shaft and across the distal opening of the outer shaft, and ii) a second electrode 1903,
    • wherein the first and second electrodes are in electrical connection with a power supply to provide a voltage therebetween.


EXAMPLE I

This prophetic example describes a preferred dual probe embodiment of the present invention.


First, after induction of an appropriate amount of a local anesthesia, the human patient is placed in a prone position on the table. The C-arm of an X-ray apparatus is positioned so that the X-rays are perpendicular to the axis of the spine. This positioning provides a lateral view of the vertebral body, thereby allowing the surgeon to view the access of the apparatus into the vertebral body.


Next, the device of the present invention is inserted into the skin at a lateral location so that its distal tip passes posterior to the dorsal nerves located outside the vertebral body.


Next, the device is advanced interiorly into the vertebral body so that the distal tip bores through the skin, into and through the cortical shell of the vertebral body. The device is advanced until the tip reaches the anterior-posterior midline of the vertebral body.


Next, the power supply is activated to provide a voltage between the active and return electrodes. The amount of voltage across the electrodes is sufficient to produce an electric current between the active and return electrodes. This current provides resistive heating of the tissue disposed between the electrodes in an amount sufficient to raise the temperature of the local portion of the basivertebral nerve (BVN) to at least 45° C., thereby denervating the BVN.

Claims
  • 1. An electrosurgical device, comprising: an elongate shaft having a proximal end and a distal end, at least a portion of said elongate shaft comprising an electrically conductive material;an intermediate spacer having a proximal end and a distal end, said intermediate spacer comprising an electrically insulating material,wherein said proximal end of said intermediate spacer is mechanically connected to said distal end of said elongate shaft; anda sharp tip comprising an electrically conductive material having a proximal end and a distal end,wherein said proximal end of said tip is mechanically connected to said distal end of said intermediate spacer,wherein said distal end of said sharp tip is configured to pierce cortical bone of a vertebral body,wherein said elongate shaft is electrically connected to a power supply via a first lead,wherein said sharp tip is connected to said power supply via a second lead,wherein said elongate shaft and said tip form a bipolar heating device, andwherein said bipolar heating device is configured to denervate an intraosseous nerve within a cancellous bone region of a vertebral body by transmission of radiofrequency energy to heat at least a portion of the cancellous bone region.
  • 2. The device of claim 1 wherein said elongate shaft is hollow, wherein said intermediate spacer is hollow, and wherein said second lead runs through said elongate shaft and said intermediate spacer.
  • 3. The device of claim 1, wherein at least a portion of said elongate shaft comprises an outer insulating sleeve to electrically isolate the shaft from adjacent tissue.
  • 4. The device of claim 3, wherein the sleeve has a length that is between 50% and 95% of the length of the shaft.
  • 5. The device of claim 1, wherein the elongate shaft is flexible.
  • 6. The device of claim 1, wherein the elongate shaft comprises a shape memory alloy.
  • 7. The device of claim 1, wherein said proximal end of said intermediate spacer extends inside said distal end of said elongate shaft, and wherein said proximal end of said sharp tip extends inside said proximal end of said intermediate spacer.
  • 8. The device of claim 7, wherein the proximal end of the sharp tip is nested through the intermediate spacer and into the distal end of the shaft, thereby imparting electrical isolation and greater strength to the device.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/643,997, now abandoned, filed Dec. 21, 2009, which is a continuation of U.S. patent application Ser. No. 11/745,446, now abandoned, filed on May 7, 2007, which is a continuation of U.S. patent application Ser. No. 10/401,854 filed on Mar. 28, 2003, now U.S. Pat. No. 7,258,690, each of which is incorporated herein by reference in its entirety. This application is also related to U.S. patent application Ser. No. 10/259,689 filed on Sep. 30, 2002, now U.S. Pat. No. 7,326,203, which is incorporated herein by reference in its entirety.

US Referenced Citations (471)
Number Name Date Kind
3845771 Vise Nov 1974 A
3920021 Hiltebrandt Nov 1975 A
4044774 Corbin et al. Aug 1977 A
4116198 Roos Sep 1978 A
4312364 Convert et al. Jan 1982 A
4448198 Turner May 1984 A
4573448 Kambin Mar 1986 A
4657017 Sorochenko Apr 1987 A
4679561 Doss Jul 1987 A
4754757 Feucht Jul 1988 A
4907589 Cosman Mar 1990 A
4950267 Ishihara et al. Aug 1990 A
4959063 Kojima Sep 1990 A
4963142 Loertscher Oct 1990 A
4966144 Rochkind et al. Oct 1990 A
5061266 Hakky Oct 1991 A
5080660 Buelna Jan 1992 A
5084043 Hertzmann et al. Jan 1992 A
5098431 Rydell Mar 1992 A
5106376 Mononen et al. Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5161533 Prass et al. Nov 1992 A
5190546 Jervis Mar 1993 A
5201729 Hertzmann et al. Apr 1993 A
5209748 Daikuzono May 1993 A
5222953 Dowlatshahi Jun 1993 A
5242439 Larsen et al. Sep 1993 A
5273026 Wilk Dec 1993 A
5281213 Milder et al. Jan 1994 A
5295484 Marcus et al. Mar 1994 A
5320617 Leach Jun 1994 A
5350377 Winston et al. Sep 1994 A
5366443 Eggers et al. Nov 1994 A
5368031 Cline et al. Nov 1994 A
5374265 Sand Dec 1994 A
5391197 Burdette et al. Feb 1995 A
5419767 Eggers et al. May 1995 A
5433739 Sluijter et al. Jul 1995 A
5437661 Rieser Aug 1995 A
5441499 Fritzsch Aug 1995 A
5443463 Stern et al. Aug 1995 A
5458596 Lax et al. Oct 1995 A
5458597 Edwards et al. Oct 1995 A
5472441 Edwards et al. Dec 1995 A
5484432 Sand Jan 1996 A
5486170 Winston et al. Jan 1996 A
5514130 Baker May 1996 A
5540684 Hassler, Jr. Jul 1996 A
5569242 Lax et al. Oct 1996 A
5571147 Sluijter et al. Nov 1996 A
5620479 Diederich Apr 1997 A
5630426 Shmulewitz et al. May 1997 A
5630837 Crowley May 1997 A
5643319 Green et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5672173 Gough et al. Sep 1997 A
5681282 Eggers et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5693052 Weaver Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697927 Imran et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5720287 Chapelon et al. Feb 1998 A
5725494 Brisken Mar 1998 A
5728062 Brisken Mar 1998 A
5733280 Avitall Mar 1998 A
5733315 Burdette et al. Mar 1998 A
5735811 Brisken Apr 1998 A
5735847 Gough et al. Apr 1998 A
5738680 Mueller et al. Apr 1998 A
5743904 Edwards Apr 1998 A
5746737 Saadat May 1998 A
5752969 Cunci et al. May 1998 A
5762066 Law et al. Jun 1998 A
5762616 Talish Jun 1998 A
5766153 Eggers et al. Jun 1998 A
5776092 Farin et al. Jul 1998 A
5785705 Baker Jul 1998 A
5800378 Edwards et al. Sep 1998 A
5807392 Eggers Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5817021 Reichenberger Oct 1998 A
5843019 Eggers et al. Dec 1998 A
5843021 Edwards et al. Dec 1998 A
5846218 Brisken et al. Dec 1998 A
5849011 Jones et al. Dec 1998 A
5855576 LeVeen et al. Jan 1999 A
5860951 Eggers et al. Jan 1999 A
5865788 Edwards et al. Feb 1999 A
5868740 LeVeen et al. Feb 1999 A
5871469 Eggers et al. Feb 1999 A
5871470 McWha Feb 1999 A
5871481 Kannenberg et al. Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5873877 McGaffigan et al. Feb 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5895370 Edwards et al. Apr 1999 A
5902272 Eggers et al. May 1999 A
5904681 West, Jr. May 1999 A
5931805 Brisken Aug 1999 A
5935123 Edwards et al. Aug 1999 A
5941722 Chen Aug 1999 A
5941876 Nardella et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5948007 Starkebaum et al. Sep 1999 A
5948008 Daikuzono Sep 1999 A
5954716 Sharkey et al. Sep 1999 A
5964727 Edwards et al. Oct 1999 A
5983141 Sluijter et al. Nov 1999 A
5997497 Nita et al. Dec 1999 A
6001095 de la Rama et al. Dec 1999 A
6007533 Casscells et al. Dec 1999 A
6007570 Sharkey et al. Dec 1999 A
6012457 Lesh Jan 2000 A
6016452 Kasevich Jan 2000 A
6017356 Frederick et al. Jan 2000 A
6022334 Edwards et al. Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6024740 Lesh et al. Feb 2000 A
6030402 Thompson et al. Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6035238 Ingle et al. Mar 2000 A
6045532 Eggers et al. Apr 2000 A
6050995 Durgin Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6053909 Shadduck Apr 2000 A
6063079 Hovda et al. May 2000 A
6066134 Eggers et al. May 2000 A
6073051 Sharkey et al. Jun 2000 A
6086585 Hovda et al. Jul 2000 A
6090105 Zepeda et al. Jul 2000 A
6095149 Sharkey et al. Aug 2000 A
6099514 Sharkey et al. Aug 2000 A
6102046 Weinstein et al. Aug 2000 A
6104957 Alo et al. Aug 2000 A
6105581 Eggers et al. Aug 2000 A
6109268 Thaliyal et al. Aug 2000 A
6113597 Eggers et al. Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6117109 Eggers et al. Sep 2000 A
6117128 Gregory Sep 2000 A
6120467 Schallhorn Sep 2000 A
6122549 Sharkey et al. Sep 2000 A
6139545 Utley et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6143019 Motamedi et al. Nov 2000 A
6146380 Racz et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6159194 Eggers et al. Dec 2000 A
6159208 Hovda et al. Dec 2000 A
6161048 Sluijter et al. Dec 2000 A
6164283 Lesh Dec 2000 A
6165172 Farley et al. Dec 2000 A
6168593 Sharkey et al. Jan 2001 B1
6176857 Ashley Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6183469 Thaliyal et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6190383 Schmaltz et al. Feb 2001 B1
6193715 Wrublewski et al. Feb 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6210393 Brisken Apr 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210415 Bester Apr 2001 B1
6221038 Brisken Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6228046 Brisken May 2001 B1
6228078 Eggers et al. May 2001 B1
6228082 Baker et al. May 2001 B1
6231571 Ellman et al. May 2001 B1
6231615 Preissman May 2001 B1
6235020 Cheng et al. May 2001 B1
6235024 Tu May 2001 B1
6238391 Olsen et al. May 2001 B1
6241665 Negus et al. Jun 2001 B1
6241725 Cosman Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6254553 Lidgren et al. Jul 2001 B1
6254599 Lesh et al. Jul 2001 B1
6254600 Willink et al. Jul 2001 B1
6258086 Ashley et al. Jul 2001 B1
6259952 Sluijter Jul 2001 B1
6261311 Sharkey et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6264651 Underwood et al. Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6264659 Ross et al. Jul 2001 B1
6267770 Truwit Jul 2001 B1
6277112 Underwood et al. Aug 2001 B1
6277122 McGahan et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6287114 Meller et al. Sep 2001 B1
6287272 Brisken et al. Sep 2001 B1
6287304 Eggers et al. Sep 2001 B1
6290715 Sharkey et al. Sep 2001 B1
6296619 Brisken et al. Oct 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6305378 Lesh et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6309420 Preissman Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6312426 Goldberg et al. Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6348055 Preissman Feb 2002 B1
6355032 Hovda et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6379351 Thaliyal et al. Apr 2002 B1
6383190 Preissman May 2002 B1
6391025 Weinstein et al. May 2002 B1
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6423059 Hanson et al. Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6436060 Talish Aug 2002 B1
6451013 Bays et al. Sep 2002 B1
6454727 Burbank et al. Sep 2002 B1
6461350 Underwood et al. Oct 2002 B1
6461354 Olsen et al. Oct 2002 B1
6464695 Hovda et al. Oct 2002 B2
6468270 Hovda et al. Oct 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6478793 Cosman et al. Nov 2002 B1
6482201 Olsen et al. Nov 2002 B1
6500173 Underwood et al. Dec 2002 B2
6527759 Tachibana et al. Mar 2003 B1
6540741 Underwood et al. Apr 2003 B1
6544261 Ellsberry et al. Apr 2003 B2
6557559 Eggers et al. May 2003 B1
6558385 McClurken et al. May 2003 B1
6560486 Osorio et al. May 2003 B1
6575968 Eggers et al. Jun 2003 B1
6582423 Thaliyal et al. Jun 2003 B1
6585656 Masters Jul 2003 B2
6589237 Woloszko et al. Jul 2003 B2
6595990 Weinstein et al. Jul 2003 B1
6602248 Sharps et al. Aug 2003 B1
6622731 Daniel et al. Sep 2003 B2
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6659106 Hovda et al. Dec 2003 B1
6699242 Heggeness Mar 2004 B2
6726684 Woloszko et al. Apr 2004 B1
6736835 Pellegrino et al. May 2004 B2
6746447 Davison et al. Jun 2004 B2
6749604 Eggers et al. Jun 2004 B1
6758846 Goble et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6772012 Ricart et al. Aug 2004 B2
6773431 Eggers et al. Aug 2004 B2
6827716 Ryan et al. Dec 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6863672 Reiley et al. Mar 2005 B2
6875219 Arramon et al. Apr 2005 B2
6881214 Cosman et al. Apr 2005 B2
6896674 Woloszko et al. May 2005 B1
6907884 Pellegrino et al. Jun 2005 B2
6915806 Pacek et al. Jul 2005 B2
6922579 Taimisto et al. Jul 2005 B2
6923813 Phillips et al. Aug 2005 B2
6960204 Eggers et al. Nov 2005 B2
6974453 Woloszko et al. Dec 2005 B2
7048743 Miller et al. May 2006 B2
7090672 Underwood et al. Aug 2006 B2
7131969 Hovda et al. Nov 2006 B1
7177678 Osorio et al. Feb 2007 B1
7179255 Lettice et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7192428 Eggers et al. Mar 2007 B2
7201731 Lundquist et al. Apr 2007 B1
7201750 Eggers et al. Apr 2007 B1
7211055 Diederich et al. May 2007 B2
7217268 Eggers et al. May 2007 B2
7258690 Sutton et al. Aug 2007 B2
7270659 Ricart et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7276063 Davison et al. Oct 2007 B2
7318823 Sharps et al. Jan 2008 B2
7326203 Papineau et al. Feb 2008 B2
7331957 Woloszko et al. Feb 2008 B2
RE40156 Sharps et al. Mar 2008 E
7346391 Osorio et al. Mar 2008 B1
7386350 Vilims Jun 2008 B2
7387625 Hovda et al. Jun 2008 B2
7393351 Woloszko et al. Jul 2008 B2
7422585 Eggers et al. Sep 2008 B1
7429262 Woloszko et al. Sep 2008 B2
7435247 Woloszko et al. Oct 2008 B2
7442191 Hovda et al. Oct 2008 B2
7468059 Eggers et al. Dec 2008 B2
7480533 Cosman et al. Jan 2009 B2
7502652 Gaunt et al. Mar 2009 B2
7507236 Eggers et al. Mar 2009 B2
7553307 Bleich et al. Jun 2009 B2
7555343 Bleich Jun 2009 B2
7645277 McClurken et al. Jan 2010 B2
7738968 Bleich Jun 2010 B2
7740631 Bleich et al. Jun 2010 B2
7749218 Pellegrino et al. Jul 2010 B2
7819826 Diederich et al. Oct 2010 B2
7819869 Godara et al. Oct 2010 B2
7824398 Woloszko et al. Nov 2010 B2
7824404 Godara et al. Nov 2010 B2
7857813 Schmitz et al. Dec 2010 B2
7901403 Woloszko et al. Mar 2011 B2
7909827 Reiley et al. Mar 2011 B2
7917222 Osorio et al. Mar 2011 B1
7918849 Bleich et al. Apr 2011 B2
7945331 Vilims May 2011 B2
7963915 Bleich Jun 2011 B2
8066702 Rittman, III et al. Nov 2011 B2
8083736 McClurken et al. Dec 2011 B2
8100896 Podhajsky Jan 2012 B2
8192424 Woloszko et al. Jun 2012 B2
8192435 Bleich et al. Jun 2012 B2
8265747 Rittman, III et al. Sep 2012 B2
8282628 Paul et al. Oct 2012 B2
8292887 Woloszko et al. Oct 2012 B2
8323279 Dahla et al. Dec 2012 B2
8355791 Moffitt Jan 2013 B2
8361067 Pellegrino et al. Jan 2013 B2
8414509 Diederich et al. Apr 2013 B2
8414571 Pellegrino et al. Apr 2013 B2
8419730 Pellegrino et al. Apr 2013 B2
8419731 Pellegrino et al. Apr 2013 B2
8425507 Pellegrino et al. Apr 2013 B2
8535309 Pellegrino et al. Sep 2013 B2
8613744 Pellegrino et al. Dec 2013 B2
8623014 Pellegrino et al. Jan 2014 B2
8628528 Pellegrino et al. Jan 2014 B2
20010001314 Davison et al. May 2001 A1
20010001811 Burney et al. May 2001 A1
20010020167 Woloszko et al. Sep 2001 A1
20010023348 Ashley et al. Sep 2001 A1
20010025176 Ellsberry et al. Sep 2001 A1
20010025177 Woloszko et al. Sep 2001 A1
20010029370 Hodva et al. Oct 2001 A1
20010029373 Baker et al. Oct 2001 A1
20010032001 Ricart et al. Oct 2001 A1
20010047167 Heggeness Nov 2001 A1
20010049522 Eggers et al. Dec 2001 A1
20010051802 Woloszko et al. Dec 2001 A1
20010056280 Underwood et al. Dec 2001 A1
20020016600 Cosman Feb 2002 A1
20020019626 Sharkey et al. Feb 2002 A1
20020026186 Woloszko et al. Feb 2002 A1
20020052600 Davison et al. May 2002 A1
20020068930 Tasto et al. Jun 2002 A1
20020095151 Dahla et al. Jul 2002 A1
20020095152 Ciarrocca et al. Jul 2002 A1
20020099366 Dahla et al. Jul 2002 A1
20020120259 Lettice et al. Aug 2002 A1
20020147444 Shah et al. Oct 2002 A1
20020151885 Underwood et al. Oct 2002 A1
20020188284 To et al. Dec 2002 A1
20020193789 Underwood et al. Dec 2002 A1
20030009164 Woloszko et al. Jan 2003 A1
20030014047 Woloszko et al. Jan 2003 A1
20030028189 Woloszko et al. Feb 2003 A1
20030040742 Underwood et al. Feb 2003 A1
20030055418 Tasto et al. Mar 2003 A1
20030084907 Pacek et al. May 2003 A1
20030097126 Woloszko et al. May 2003 A1
20030097129 Davison et al. May 2003 A1
20030130655 Woloszko et al. Jul 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030181963 Pellegrino et al. Sep 2003 A1
20030208194 Hovda et al. Nov 2003 A1
20030216725 Woloszko et al. Nov 2003 A1
20030216726 Eggers et al. Nov 2003 A1
20040006339 Underwood et al. Jan 2004 A1
20040024399 Sharps et al. Feb 2004 A1
20040054366 Davison et al. Mar 2004 A1
20040087937 Eggers et al. May 2004 A1
20040133124 Bates et al. Jul 2004 A1
20040162559 Arramon Aug 2004 A1
20040193151 To et al. Sep 2004 A1
20040220577 Cragg et al. Nov 2004 A1
20040230190 Dahla et al. Nov 2004 A1
20050004634 Ricart et al. Jan 2005 A1
20050010203 Edwards et al. Jan 2005 A1
20050010205 Hovda et al. Jan 2005 A1
20050182417 Pagano Aug 2005 A1
20050192564 Cosman et al. Sep 2005 A1
20050209659 Pellegrino et al. Sep 2005 A1
20050283148 Janssen et al. Dec 2005 A1
20060004369 Patel et al. Jan 2006 A1
20060064101 Arramon Mar 2006 A1
20060095026 Ricart et al. May 2006 A1
20060095028 Bleich May 2006 A1
20060122458 Bleich Jun 2006 A1
20060129101 McGuckin Jun 2006 A1
20060178670 Woloszko et al. Aug 2006 A1
20060229625 Truckai et al. Oct 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060264957 Cragg et al. Nov 2006 A1
20060276749 Selmon et al. Dec 2006 A1
20070118142 Krueger et al. May 2007 A1
20070129715 Eggers et al. Jun 2007 A1
20070149966 Dahla et al. Jun 2007 A1
20070179497 Eggers et al. Aug 2007 A1
20070260237 Sutton et al. Nov 2007 A1
20080004621 Dahla et al. Jan 2008 A1
20080004675 King et al. Jan 2008 A1
20080009847 Ricart et al. Jan 2008 A1
20080021447 Davison et al. Jan 2008 A1
20080021463 Georgy Jan 2008 A1
20080058707 Ashley et al. Mar 2008 A1
20080114364 Goldin et al. May 2008 A1
20080119844 Woloszko et al. May 2008 A1
20080119846 Rioux May 2008 A1
20080132890 Woloszko et al. Jun 2008 A1
20080161804 Rioux et al. Jul 2008 A1
20080275458 Bleich et al. Nov 2008 A1
20090030308 Bradford et al. Jan 2009 A1
20090069807 Eggers et al. Mar 2009 A1
20090105775 Mitchell et al. Apr 2009 A1
20090118731 Young et al. May 2009 A1
20090131867 Liu et al. May 2009 A1
20090131886 Liu et al. May 2009 A1
20090222053 Gaunt et al. Sep 2009 A1
20090312764 Marino Dec 2009 A1
20100016929 Prochazka Jan 2010 A1
20100023006 Ellman Jan 2010 A1
20100082033 Germain Apr 2010 A1
20100094269 Pellegrino et al. Apr 2010 A1
20100114098 Carl May 2010 A1
20100145424 Podhajsky et al. Jun 2010 A1
20100185161 Pellegrino et al. Jul 2010 A1
20100211076 Germain et al. Aug 2010 A1
20100222777 Sutton et al. Sep 2010 A1
20100298832 Lau et al. Nov 2010 A1
20100324506 Pellegrino et al. Dec 2010 A1
20110022133 Diederich et al. Jan 2011 A1
20110034884 Pellegrino et al. Feb 2011 A9
20110040362 Godara et al. Feb 2011 A1
20110077628 Hoey et al. Mar 2011 A1
20110087314 Diederich et al. Apr 2011 A1
20110196361 Vilims Aug 2011 A1
20110264098 Cobbs Oct 2011 A1
20110276001 Schultz et al. Nov 2011 A1
20110319765 Gertner et al. Dec 2011 A1
20120029420 Rittman, III et al. Feb 2012 A1
20120196251 Taft et al. Aug 2012 A1
20120197344 Taft et al. Aug 2012 A1
20120203219 Evans et al. Aug 2012 A1
20120226273 Nguyen et al. Sep 2012 A1
20120239050 Linderman Sep 2012 A1
20120330180 Pellegrino et al. Dec 2012 A1
20120330300 Pellegrino et al. Dec 2012 A1
20120330301 Pellegrino et al. Dec 2012 A1
20130006232 Pellegrino et al. Jan 2013 A1
20130006233 Pellegrino et al. Jan 2013 A1
20130012933 Pellegrino et al. Jan 2013 A1
20130012935 Pellegrino et al. Jan 2013 A1
20130012936 Pellegrino et al. Jan 2013 A1
20130103022 Pellegrino et al. Apr 2013 A1
20130261507 Diederich et al. Oct 2013 A1
20130324994 Pellegrino et al. Dec 2013 A1
20130324996 Pellegrino et al. Dec 2013 A1
20130324997 Pellegrino et al. Dec 2013 A1
20140039500 Pellegrino et al. Feb 2014 A1
Foreign Referenced Citations (33)
Number Date Country
0040658 Dec 1981 EP
0584959 Mar 1994 EP
0597463 May 1994 EP
1013228 Jun 2000 EP
1059067 Dec 2000 EP
1059087 Dec 2000 EP
6-47058 Feb 1994 JP
2001-037760 Feb 2001 JP
2002-531229 Sep 2002 JP
WO 9636289 Nov 1996 WO
WO 9827876 Jul 1998 WO
WO 9834550 Aug 1998 WO
WO 9919025 Apr 1999 WO
WO 9944519 Sep 1999 WO
WO 9948621 Sep 1999 WO
WO 0021448 Apr 2000 WO
WO 0033909 Jun 2000 WO
WO 0049978 Aug 2000 WO
WO 0056237 Sep 2000 WO
WO 0067648 Nov 2000 WO
WO 0067656 Nov 2000 WO
WO 0101877 Jan 2001 WO
WO 0126570 Apr 2001 WO
WO 0145579 Jun 2001 WO
WO 0157655 Aug 2001 WO
WO 0205699 Jan 2002 WO
WO 0228302 Apr 2002 WO
WO 02054941 Jul 2002 WO
WO 02067797 Sep 2002 WO
WO 02096304 Dec 2002 WO
WO2007031264 Mar 2007 WO
WO 2008008522 Jan 2008 WO
WO 2008121259 Oct 2008 WO
Non-Patent Literature Citations (41)
Entry
The AVAmax System—Cardinal Health Special Procedures, Lit. No. 25P0459-01—www.cardinal.com (2007).
Mary S. Sherman; The Nerves of Bone, The Journal of Bone and Joint Surgery, Apr. 1963, pp. 522-528, vol. 45-A, No. 3.
Michael H. Heggeness, et al., The Trabecular Anatomy of Thoracolumbar Vertebrae: Implications for Burst Fractures, Journal of Anatomy, 1997, pp. 309-312, vol. 191, Great Britain.
J.B. Martin, et al., Vertebroplasty: Clinical Experience and Follow-up Results, Bone, Aug. 1999, pp. 11S-15S, vol. 25, No. 2, Supplement.
H. Deramond, et al., Temperature Elevation Caused by Bone Cement Polymerization During Vertebroplasty, Bone, Aug. 1999, pp. 17S-21S, vol. 25, No. 2, Supplement.
D.E. Dupuy et al. Radiofrequency ablation of spinal tumors: Temperature distribution in the spinal canal AJR, vol. 175, pp. 1263-1266, Nov. 2000.
C.L. Tillotson et al. Controlled thermal injury of bone: Report of a percutaneous technique using radiofrequency electrode and generator. Investigative Radiology, Nov. 1989, pp. 888-892.
Cosman, E.R. et al. Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone. Neurosurgery, vol. 1, No. 6, 1984, pp. 945-950.
S.N. Goldberg et al. Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volume, Acad. Radiol., vol. 2, pp. 399-404 (1995).
D.I. Rosenthal. Seminars in Musculoskeletal Radiology, vol. 1, No. 2, pp. 265-272 (1997).
L. Solbiati et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Interventional Radiology, vol. 205, No. 2, pp. 367-373 (1997).
Massad, Malek M.D. et al.; Endoscopic Thoracic Sympathectomy: Evaluation of Pulsatile Laser, Non-Pulsatile Laser, and Radiofrequency-Generated Thermocoagulation; Lasers in Surgery and Medicine; 1991; pp. 18-25.
Kleinstueck, Frank S. et al.; Acute Biomechanical and Histological Effects of Intradiscal Electrothermal Therapy on Human Lumbar Discs; SPINE vol. 26, No. 20, pp. 2198-2207; 2001, Lippincott Williams & Wilkins, Inc.
Heggeness, Michael H. et al. Discography Causes End Plate Deflection; SPINE vol. 18, No. 8, pp. 1050-1053, 1993, J.B. Lippincott Company.
Letcher, Frank S. et al.; The Effect of Radiofrequency Current and Heat on Peripheral Nerve Action Potential in the Cat; U.S. Naval Hospital, Philadelphia, PA (1968).
Houpt, Jonathan C. et al.; Experimental Study of Temperature Distributions and Thermal Transport During Radiofrequency Current Therapy of the Intervertebral Disc; SPINE vol. 21, No. 15, pp. 1808-1813, 1996, Lippincott-Raven Publishers.
Lundskog, Jan; Heat and Bone Tissue-/an experimental investigation of the thermal properties of bone tissue and threshold levels for thermal injury; Scandinavian Journal of Plastic and Reconstructive Surgery Supplemental 9, From the Laboratory of Experimental Biology, Department of anatomy, University of Gothenburg, Gothenburg, Sweden, Goteborg (1972).
Antonacci, M. Darryl et al.; Innervation of the Human Vertebral Body: A Histologic Study; Journal of Spinal Disorder, vol. 11, No. 6, pp. 526-531, 1998 Lippincott Williams & Wilkins, Philadelphia.
Arnoldi, Carl C.; Intraosseous Hypertension—A Possible Cause of Low Back Pain?; Clinical Orthopedics and Related Research, No. 115, Mar.-Apr. 1976.
Esses, Stephen I. et al.; Intraosseous Vertebral Body Pressures; SPINE vol. 17 No. 6 Supplement (1992).
Troussier, B. et al.; Percutaneous Intradiscal Radio-Frequency Thermocoagulation A Cadaveric Study; SPINE vol. 20, No. 15, pp. 1713-1718, 1995, Lippincott-Raven Publishers.
Choy, Daniel SS.J. et al.; Percutaneous Laser Disc Decompression, A New Therapeutic Modality; SPINE vol. 17, No. 8 (1992).
Shealy, C. Norman; Percutaneous radiofrequency denervation of spinal facets: Treatment for chronic back pain and sciatica; Journal of Neurosurgery/vol. 43/Oct. 1975.
Depuy, Damian E.; Radiofrequency Ablation: An Outpatient Percutaneous Treatment; Medicine and Health/Rhode Island vol. 82, No. 6, Jun. 1999.
Rashbaum, Ralph F.; Radiofrequency Facet Denervation A Treatment alternative in Refractory Low Back Pain with or without Leg Pain; Orthopedic Clinics of North America—vol. 14, No. 3, Jul. 1983.
Lehmann, Justus F. et al.; Selective Heating Effects of Ultrasound in Human Beings; Archives of Physical Medicine & Rehabilitation Jun. 1966.
Hanai, Kenji et al.; Simultaneous Measurement of Intraosseous and Cerebrospinal Fluid Pressures in the Lumbar Region; SPINE vol. 10, No. 1 (1985).
Bogduk, Nikolai, et al.; Technical Limitations to the efficacy of Radiofrequency Neurotomy for Spinal Pain; Neurosurgery vol. 20, No. 4 (1987).
Mehta, Mark et al.; The treatment of chronic back pain; Anaesthesia, 1979, vol. 34, pp. 768-775.
Deardorff, Dana L. et al.; Ultrasound applicators with internal cooling for interstitial thermal therapy; SPIE vol. 3594 (1999).
Diederich, Chris J. et al.; Ultrasound Catheters for Circumferential Cardiac Ablation; SPIE vol. 3594 (1999).
Diederich C J, et al. “IDTT Therapy in Cadaveric Lumbar Spine: Temperature and thermal dose distributions, Thermal Treatment of Tissue: Energy Delivery and Assessment,” Thomas P. Ryan, Editor, Proceedings of SPIE vol. 4247:104-108 (2001).
Nau, William H., Ultrasound interstitial thermal therapy (USITT) in the prostate; SPIE vol. 3594 (1999).
The AVAmax System—Cardinal Health Special Procedures, Lit. No. 25P0459-01—www.cardinal.com (allegedly dated 2007).
Kopecky, Kenyon K. et al. “Side-Exiting Coaxial Needle for Aspiration Biopsy”—AJR—1996; 167, pp. 661-662.
A Novel Approach for Treating Chronic Lower Back Pain, Abstract for Presentation at North American Spine Society 26th Annual Meeting in Chicago, IL on Nov. 4, 2011.
Stanton, Terry, “Can Nerve Ablation Reduce Chronic Back Pain?” AAOS Now Jan. 2012.
Ryan et al., “Three-Dimensional Finite Element Simulations of Vertebral Body Thermal Treatment,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 137-155.
Bergeron et al., “Fluoroscopic-guided radiofrequency ablation of the basivertebral nerve: application and analysis with multiple imaging modalities in an ovine model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 156-167.
Hoopes et al., “Radiofrequency Ablation of The Basivertebral Nerve as a Potential Treatment of Back Pain: Pathologic Assessment in an Ovine Model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 168-180.
FDA Response to 510(k) Submission by Relievant Medsystems, Inc. submitted on Sep. 27, 2007 (date stamped on Oct. 5, 2007) and associated documents.
Related Publications (1)
Number Date Country
20130103022 A1 Apr 2013 US
Continuations (3)
Number Date Country
Parent 12643997 Dec 2009 US
Child 13655683 US
Parent 11745446 May 2007 US
Child 12643997 US
Parent 10401854 Mar 2003 US
Child 11745446 US